NewAmsterdam Pharma (NAMS) Non-Current Assets (2021 - 2026)
NewAmsterdam Pharma's Non-Current Assets came in at $45.25 million for Q2 2026, unchanged from $45.26 million a year earlier and down 39.3% from the prior quarter.
Powered by 
Analysis
NewAmsterdam Pharma (NAMS) Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, NewAmsterdam Pharma's Non-Current Assets was $93.58 million.
- Non-Current Assets carries a four-year compound annual growth rate of 205.5% (FY2021 to FY2025).
- Going back by year, Non-Current Assets was $1.21 million in FY2024 (+294.4%), $306,000 in FY2023 (-99.7%), $87.95 million in FY2022 and $1.07 million in FY2021.
- The Q2 2026 figure represents the lowest quarterly Non-Current Assets since Q1 2025.
- Business Quant data shows NAMS's Non-Current Assets at $74.6 million (Q1 2026), $93.58 million (Q4 2025) and $54.1 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | NewAmsterdam Pharma | 2.77 Bn | 2.77 Bn | - | 45.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 45.25 Mn |
| Mar 31, 2026 | 74.60 Mn |
| Dec 31, 2025 | 93.58 Mn |
| Sep 30, 2025 | 54.10 Mn |
| Jun 30, 2025 | 45.26 Mn |
| Mar 31, 2025 | 1.11 Mn |
| Dec 31, 2024 | 1.21 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 641,000.00 |
| Dec 31, 2023 | 306,000.00 |
| Jun 30, 2023 | 89.11 Mn |
| Dec 31, 2022 | 85.14 Mn |
| Dec 31, 2021 | 1.04 Mn |
API Access
NewAmsterdam Pharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NAMS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NAMS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NAMS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();